Research Topics
| M J BarrySummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
PSA screening for prostate cancer: the current controversy--a viewpoint. Patient Outcomes Research Team for Prostatic DiseasesM J Barry
General Medicine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, USA
Ann Oncol 9:1279-82. 1998..A shared approach to decisions about screening individual patients pending better evidence is one strategy for clinicians to consider in dealing with this controversial problem...- Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging menJ B Meigs
General Medicine Unit, Medical Services, Massachusetts General Hospital and Harvard Medical School, 50 Staniford Street, Boston, MA 02114, USA
J Clin Epidemiol 54:935-44. 2001..Risk associated with heart disease does not appear to be due solely to detection bias or to effects of heart disease medications. A wide variety of other characteristics appear to have no influence on risk for clinical BPH... 
Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physiciansM M Collins
General Medicine Division, Massachusetts General Hospital, Boston 02114, USA
J Gen Intern Med 12:224-9. 1997..Some of their diagnostic evaluations vary from the recommendations of a national guideline and urologists' practices. Referral thresholds appear to vary considerably...- Measurement of overall and disease-specific health status: does the order of questionnaires make a difference?M J Barry
Medical Practices Evaluation Center, Massachusetts General Hospital, Boston, USA
J Health Serv Res Policy 1:20-7. 1996..This study was designed to detect any effect of order when modules on disease-specific and overall health status are combined in an outcomes research questionnaire... - Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysisM J Barry
General Medicine Division, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Cancer 91:2302-14. 2001..The authors sought to define the outcomes of three common strategies for managing patients with nonmetastatic prostate carcinoma: expectant management, radiotherapy, and radical prostatectomy... - Interpreting results of prostate-specific antigen testing for early detection of prostate cancerJ B Meigs
General Internal Medicine Unit, Massachusetts General Hospital, Boston 02114, USA
J Gen Intern Med 11:505-12. 1996..Likelihood ratios demonstrate that the ability of the PSA test to discriminate potentially curable prostate cancer from BPH is dramatically lower in men selected with lower urinary tract symptoms than in randomly selected men... - The prevalence and implications of incidental findings on ED abdominal CT scansW A Messersmith
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
Am J Emerg Med 19:479-81. 2001..Although work-up of these 11 cases did not yield any serious diagnoses, many potentially serious incidental findings without follow-up remain worrisome... - Evaluation of symptoms and quality of life in men with benign prostatic hyperplasiaM J Barry
Medical Practices Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA
Urology 58:25-32; discussion 32. 2001..Men with a severe burden of lower urinary tract symptoms often have measurable decrements in overall health-related quality of life, which can be ameliorated by treatment... - Fecal occult blood testing for colorectal cancer: a perspectiveM J Barry
Medical Practices Evaluation Center, Massachusetts General Hospital, Boston, USA
Ann Oncol 13:61-4. 2002..Whether and how to implement population-based screening for colorectal cancer depends largely on available resources...